The Online Investor
Stock Buybacks
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ANIK Buyback image

Anika Therapeutics, Inc. Buyback

OLI recorded this information on 2/24/2016

Company: Anika Therapeutics, Inc.
Buyback: ANIK buyback
$Amount Authorized: $25,000,000
Buyback Details: Anika Therapeutics, Inc., (NASDAQ:ANIK), a global, integrated orthopedics medicines company specializing in therapeutics based on its proprietary hyaluronic acid technology, today announced that it will enter into an accelerated share repurchase ("ASR") program to repurchase $25 million of its outstanding common stock.

Anika Therapeutics is a global joint preservation company. Co. has divided its product portfolio into three product families: Joint Pain Management, which include Monovisc and Orthovis, Cingal and Hyvisc; Joint Preservation and Restoration, which include bone preserving joint technologies; soft tissue repair and regenerative solutions; and Other, which consists of Hyalobarrier, an anti-adhesion barrier indicated for use after abdomino-pelvic surgeries, and Hyalomatrix, which is used for the treatment of complex wounds such as burns and ulcers, products used in connection with the treatment of ears, nose and throat disorders, and ophthalmic products.

ANIK SEC Filing Email Alerts Service

Open the ANIK Page at The Online Investor »

Company Name:  Anika Therapeutics Inc.
Stock buyback:  ANIK buyback
Sector:  Medical Instruments & Supplies
Number of ETFs Holding ANIK:  47
Total Market Value Held by ETFs:  $127.96M
Total Market Capitalization:  $600.00M
% of Market Cap. Held by ETFs:  21.33%

Open the ANIK Page at The Online Investor (in a new window) »

October 26, 2021    7:03 AM Eastern
Quotes delayed 20 minutes

Email EnvelopeFree ANIK Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.00 out of 4)
24th percentile
(ranked lower than approx. 76% of all stocks covered)

Analysts' Target Price:
ANIK Stock Forecast

Based on Zacks ABR data;
powered by Xignite

ANIK Buyback | | Copyright © 1998 - 2021, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.